Diponed Bio is a pioneering regenerative medicine company focused on translating cutting-edge biologics and cell therapy innovations into clinician-ready solutions. Based in India with a globally aligned strategy, we bridge the gap between laboratory research and real-world therapeutic deployment through our integrated platform of medical devices, advanced biologics, and cell & gene therapy (CGT) technologies.
Our mission is to democratize access to Advanced Therapy Medicinal Products (ATMPs) by developing scalable, regulatory-compliant platforms that enable healthcare providers to deliver next-generation regenerative treatments with confidence and precision. We don't just develop products—we create complete translational pathways from bench to bedside.
Diponed Bio specializes in developing and deploying regenerative medicine solutions across multiple therapeutic modalities:
Next-generation platelet-rich plasma and platelet-rich fibrin matrix systems designed for enhanced growth factor delivery and sustained therapeutic release
Comprehensive platforms utilizing mesenchymal stem cells (MSC), mononuclear cells (MNC), very small embryonic-like stem cells (VSEL), and cytokine-induced killer cells (CIK) for diverse regenerative applications
Advanced extracellular vesicle technologies for cell-free regenerative therapy and targeted tissue repair
Safer, more accessible gene modification approaches that eliminate viral vector risks while maintaining therapeutic efficacy
End-to-end support from protocol development to clinical implementation, ensuring seamless technology transfer to healthcare facilities
What sets Diponed Bio apart is our integrated, translation-first methodology that prioritizes clinical readiness at every stage:
Seamless integration of research insights into commercial-grade product pipelines, ensuring scientific rigor meets practical applicability
Good Manufacturing Practice-compliant facilities and protocols that meet international quality standards for biologics production
Turn-key solutions with standardized procedures, comprehensive training materials, and ongoing technical support for healthcare providers
Proactive regulatory engagement and documentation frameworks designed to accelerate approval pathways across multiple jurisdictions
Our regenerative medicine solutions target high-impact clinical needs across multiple medical specialties:
Joint repair, osteoarthritis management, and sports medicine applications
Advanced healing solutions for non-healing wounds and diabetic complications
Anti-inflammatory biologics for chronic disease management and tissue restoration
Regenerative solutions for cosmetic enhancement and scar revision
Adjunctive therapies to enhance recovery and quality of life during cancer treatment
Expanding therapeutic horizons across neurology, cardiology, and beyond
Our unique approach positions us as the ideal partner for healthcare providers seeking advanced regenerative solutions:
While others focus solely on research, we prioritize clinical translation from day one, ensuring every innovation has a clear pathway to patient care.
Our unique multi-modal approach combines medical devices, biologics manufacturing, and cell therapy expertise under one roof for comprehensive solutions.
We leverage India's emerging biotech ecosystem while maintaining alignment with international regulatory frameworks and quality standards.
Making advanced regenerative therapies accessible through efficient development processes and scalable manufacturing approaches.
Ready to explore how our regenerative medicine solutions can transform patient outcomes in your practice?
PRP, PRFM, Stem Cell Therapy, Cell Therapy India, CGT, ATMP, Regenerative Medicine, Exosomes, Biologics Manufacturing, Translational Medicine, Platelet-Rich Plasma, Mesenchymal Stem Cells, MSC, MNC, VSEL, CIK Cells, Gene Therapy, Non-Viral Gene Therapy, Advanced Therapy Medicinal Products, GMP Biologics, Cartilage Regeneration, Chronic Wound Healing, Diabetic Foot Ulcer Treatment, Aesthetic Regeneration, Oncology Supportive Care, Cell Processing, Clinical Deployment, Regenerative Biologics, India Biotech